[2]. National Institute of Health and Care Excellence (NICE). Cardiovascular disease: risk assessment and reduction, including lipid modification.NICE, 2023, NICE guideline NG238. [3]. Lancet.2010;376(9753):1670-81. [4]. Nati...
[2]. National Institute of Health and Care Excellence (NICE). Cardiovascular disease: risk assessment and reduction, including lipid modification.NICE, 2023, NICE guideline NG238. [3]. Lancet.2010;376(9753):1670-81. [4]. National Institute of Health and Care Excellence (NICE). Evidence rev...
本次更新聚焦CVD风险评估及风险沟通、以人为中心的照护和生活方式改变、用于预防CVD的他汀治疗这三个方面。 图片由Unsplash提供 原文献信息: Cardiovascular disease risk assessment and reduction: summary of updated NICE guidance. Samaraseker...
Cardiovasculardisease: riskassessmetand reduction,includinglipid modification NICEguideline Published:14December2023 .uk/guidance/ng238 ©NICE2023.Allrightsreserved.SubjecttoNoticeofrights(.uk/terms-and- conditions#notice-of-rights). Cardiovasculardisease:riskassessmentandreduction,includinglipidmodification ...
The UK NICE, in partnership with the National Collaborating Centre for Primary Care (NCC PC), has issued new guidance to the NHS in England and Wales on the identification of individuals at risk for cardiovascular disease (CVD), and on the use of lipid-lowering drugs to reduce that risk. ...
cardiovascular disease. [2013] 1.8.2 Provide information on how people who smoke can reduce the risk of illness and death (to themselves and others) by using 1 or more medicinally licensed nicotine-containing products. Explain that they
Cardiovascular disease (CVD) is the leading cause of death inEngland and Wales, accounting for almost a third of deaths. Anupdate of existing National Institute for Health and CareExcellence (NICE) guidance (published in 2008)1 was necessaryin light of new evidence on the efficacy and safety ...
而针对动脉粥样硬化心血管疾病(arterioscleroticcardiovasculardisease, ASCVD),《中国血脂管理指南(2023年)》则推荐采用“中国成人ASCVD总体 发病风险评估流程图〃进行风险评估,对V55岁且ASCVD10年风险为中危者进 一步进行终身风险评估。2个流程图目前为我国指南最新的CVD风险评估工具, 且内容基本一致,而后者更具针对性。
The NICE guidance on statins -- what's new? British Journal of Primary Care Nursing. Cardiovascular Disease & DiabetesJarvis S
Topics discussed include the use of QRISK2 as cardiovascular risk assessment to prevent cardiovascular disease (CVD), the division of the statin drugs and dosages into low, medium, and high-intensity, and the use of atorvastatin to initiate statins....